|
ST13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.56500004253746E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.28909999528449E-08 |
| Normal-vs-Stage2 |
4.770900E-04 |
| Normal-vs-Stage3 |
7.89670000500564E-08 |
| Normal-vs-Stage4 |
1.97590000028391E-07 |
| Stage1-vs-Stage2 |
7.850600E-01 |
| Stage1-vs-Stage3 |
4.726000E-01 |
| Stage1-vs-Stage4 |
1.924590E-01 |
| Stage2-vs-Stage3 |
4.805600E-01 |
| Stage2-vs-Stage4 |
2.545600E-01 |
| Stage3-vs-Stage4 |
4.784600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.20510004384545E-09 |
| Normal-vs-AfricanAmerican |
6.638700E-03 |
| Normal-vs-Asian |
4.43340000000347E-06 |
| Caucasian-vs-AfricanAmerican |
4.606000E-01 |
| Caucasian-vs-Asian |
8.233200E-01 |
| AfricanAmerican-vs-Asian |
4.527200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.03999999512672E-08 |
| Normal-vs-Female |
3.91590000425879E-08 |
| Male-vs-Female |
2.805200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.68949999949042E-07 |
| Normal-vs-Age(41-60Yrs) |
8.22900000363447E-08 |
| Normal-vs-Age(61-80Yrs) |
1.90189999971224E-07 |
| Normal-vs-Age(81-100Yrs) |
3.420600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.709400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.937200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.804600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.613000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.689000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.573600E-01 |
| Classical-VS-Follicular |
3.787800E-02 |
| Classical-VS-Other |
2.440600E-01 |
| Classical-VS-Normal |
1.6660000001778E-07 |
| Tall-VS-Follicular |
1.576580E-01 |
| Tall-VS-Other |
3.090200E-01 |
| Tall-VS-Normal |
6.011200E-04 |
| Follicular-VS-Other |
8.070800E-01 |
| Follicular-VS-Normal |
2.94160000025023E-07 |
| Other-VS-Normal |
5.238000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.02249999473148E-08 |
| Normal-vs-N1 |
1.72420000499329E-08 |
| N0-vs-N1 |
1.482030E-01 |
|
|
